Emcure Pharmaceuticals files papers for Rs 4500-crore IPO
[email protected]12 Oct, 2021News
Emcure Pharmaceuticals, one of the leading pharma companies in India, has filed papers with markets regulator SEBI to raise funds via an initial public offer (IPO). It will list the shares on NSE and BSE. The company is looking to raise up to Rs 4,500-5,000 crore in an offer that would consist of a fresh issue of shares and an offer for sale (OFS). The fresh issue is likely to be worth Rs 1,100 crore whereas the offer for sale would be worth Rs 3,400 crore. Promoters and private equity investors are looking to offload their shares via the IPO.
Related Bookmarks
- Gennova vax gets nod for ph 2/3 trials
- Indias first mRNA vaccine phase-I clinical trial gets nod
- Gennova�s m RNA vaccine gets clearance for Phase 2/3 clinical trials
- Coconut Milk Powder: How it�s made and Essential Uses
- Clinical Director, Consultant Reproductive Medicine
- Mit lokaler SEO Suchmaschinenoptimierung auf Platz eins!
- Effective Pinterest Marketing Strategies
- new homes in Debary FL
- How Emcure Pharma owner built a Rs 6,000 Cr business empire on the back of Rs 3 lakh bank loan
- Fire Inspections Can Foster a Workplace Culture of Prevention - FireLab
Recent Profiles
Onericoverseas
Luxury Tours In Morocco
Jili9bet Ph
Shiksharesearch89
Shramik Krishi Kendra
Commercial Roofers Of Las Vegas
Pkr Slot Game
Iam Center For Integrative Aesthetic Med
Sweetbonanzahu
Naturalmelo